The global Medical Grade Chitosan market was valued at US$ 35 million in 2022 and is projected to reach US$ 58 million by 2029, at a CAGR of 7.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Medical Grade Chitosan Market aims to provide a comprehensive presentation of the global market for Medical Grade Chitosan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Grade Chitosan. Medical Grade Chitosan Market contains market size and forecasts of Medical Grade Chitosan in global, including the following market information:
Global Medical Grade Chitosan Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Grade Chitosan Market Sales, 2018-2023, 2024-2029, (Ton)
Global top five Medical Grade Chitosan companies in 2022 (%)
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
We surveyed the Medical Grade Chitosan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Grade Chitosan Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global Medical Grade Chitosan Market Segment Percentages, by Type, 2022 (%)
- Animal Origin Chitosan
- Plant Based Chitosan
Global Medical Grade Chitosan Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global Medical Grade Chitosan Market Segment Percentages, by Application, 2022 (%)
- Wound Care
- Healthcare Products
- Antibacterial Products
- Others
Global Medical Grade Chitosan Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global Medical Grade Chitosan Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Medical Grade Chitosan revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Medical Grade Chitosan revenues share in global market, 2022 (%)
- Key companies Medical Grade Chitosan sales in global market, 2018-2023 (Estimated), (Ton)
- Key companies Medical Grade Chitosan sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Primex
- KitoZyme
- BIO21
- YSK
- Vietnam Food
- NovaMatrix
- KIMICA
- Ningbo Zhenhai Haixin Biological
- Golden-Shell Pharmaceutical
- Zhejiang Fengrun Biotech
- Jiangsu Shuanglin
- Jiangsu Aoxin Biotechnology
- Qingdao Yunzhou Biochemistry
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Medical Grade Chitosan, market overview.
- Chapter 2: Global Medical Grade Chitosan market size in revenue and volume.
- Chapter 3: Detailed analysis of Medical Grade Chitosan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Medical Grade Chitosan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Medical Grade Chitosan capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
Industry Market Size
